$DYAI Dyadic to Attend Future Food Tech Event Marc
Post# of 78
(Total Views: 134)
Posted On: 03/21/2024 10:42:48 AM
$DYAI Dyadic to Attend Future Food Tech Event March 21 – 22, 2024 in San Francisco, California
https://www.globenewswire.com/news-release/20...ornia.html
JUPITER, Fla., March 21, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective, affordable and accessible biopharmaceutical products for human and animal health, and alternative proteins for food, nutrition and wellness, today announced that Joseph Hazelton, Chief Business Officer and Doug Pace, Executive Vice President of Business Development will be attending the Future Food-Tech “Innovation & Investment from Farm to Fork” event March 21 – 22, 2024 at the San Francisco Marriott Marquis in California.
Dyadic will be showcasing its Dapibus™ Microbial Expression System and providing updates on the progress of current products under development within its alternative proteins business unit. We believe this system holds promise for revolutionizing protein expression and production in various industries, including food, nutrition, and healthcare.
Moreover, Dyadic has recently entered into a co-marketing partnership with Biftek, Inc. (“Biftek”). This partnership aims to promote Biftek's patent-pending animal-free growth medium supplement, designed to reduce the costs associated with expensive culture media components such as bovine albumin. Under the terms of the partnership, Dyadic will provide promotional support for Biftek's growth media supplement. In return, Dyadic will receive a percentage of all net sales generated by Biftek for the supplement.
“We are excited to be attending the Future Food-Tech conference this week to highlight the progress of Dyadic’s expanding pipeline of cell culture media and alternative protein products,” said Joe Hazelton, Dyadic's Chief Business Officer. “We believe the Dapibus™ system coupled with our industrial heritage for producing affordable recombinant products at large scales will reduce the costs of the most expensive components of cell culture media such as transferrin and bovine albumin. Our partnership with Biftek augments our ability to further reduce the costs of media and this collaboration underscores Dyadic's commitment to advancing innovative solutions in the biotechnology and alternative proteins space while also leveraging strategic partnerships to drive mutual growth and success,” added Hazelton.
If you would like to schedule a meeting with our management members at Future Food Tech in San Francisco, please contact Heidi Zosiak at hzosiak@dyadic.com or stop by the Dyadic International, Inc. booth (#20).
https://www.globenewswire.com/news-release/20...ornia.html
JUPITER, Fla., March 21, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective, affordable and accessible biopharmaceutical products for human and animal health, and alternative proteins for food, nutrition and wellness, today announced that Joseph Hazelton, Chief Business Officer and Doug Pace, Executive Vice President of Business Development will be attending the Future Food-Tech “Innovation & Investment from Farm to Fork” event March 21 – 22, 2024 at the San Francisco Marriott Marquis in California.
Dyadic will be showcasing its Dapibus™ Microbial Expression System and providing updates on the progress of current products under development within its alternative proteins business unit. We believe this system holds promise for revolutionizing protein expression and production in various industries, including food, nutrition, and healthcare.
Moreover, Dyadic has recently entered into a co-marketing partnership with Biftek, Inc. (“Biftek”). This partnership aims to promote Biftek's patent-pending animal-free growth medium supplement, designed to reduce the costs associated with expensive culture media components such as bovine albumin. Under the terms of the partnership, Dyadic will provide promotional support for Biftek's growth media supplement. In return, Dyadic will receive a percentage of all net sales generated by Biftek for the supplement.
“We are excited to be attending the Future Food-Tech conference this week to highlight the progress of Dyadic’s expanding pipeline of cell culture media and alternative protein products,” said Joe Hazelton, Dyadic's Chief Business Officer. “We believe the Dapibus™ system coupled with our industrial heritage for producing affordable recombinant products at large scales will reduce the costs of the most expensive components of cell culture media such as transferrin and bovine albumin. Our partnership with Biftek augments our ability to further reduce the costs of media and this collaboration underscores Dyadic's commitment to advancing innovative solutions in the biotechnology and alternative proteins space while also leveraging strategic partnerships to drive mutual growth and success,” added Hazelton.
If you would like to schedule a meeting with our management members at Future Food Tech in San Francisco, please contact Heidi Zosiak at hzosiak@dyadic.com or stop by the Dyadic International, Inc. booth (#20).
(0)
(0)